Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)

Maxim Shevtsov,1–4 Boris Nikolaev,5 Yaroslav Marchenko,5 Ludmila Yakovleva,5 Nikita Skvortsov,5 Anton Mazur,6 Peter Tolstoy,6 Vyacheslav Ryzhov,7 Gabriele Multhoff2 1Department of Cell Biotechnology, Institute of Cytology of the Russian Academy of Sciences, St Petersburg, Russia; 2Departm...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shevtsov M, Nikolaev B, Marchenko Y, Yakovleva L, Skvortsov N, Mazur A, Tolstoy P, Ryzhov V, Multhoff G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	brain tumor glioblastoma tumor targeting chitosan superparamagnetic iron oxide nanoparticles magnetic resonance imaging. Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/83ebd877e047494ab1723610e2cacd42
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:83ebd877e047494ab1723610e2cacd42
record_format	dspace
institution	DOAJ
collection	DOAJ
language	EN
topic	brain tumor glioblastoma tumor targeting chitosan superparamagnetic iron oxide nanoparticles magnetic resonance imaging. Medicine (General) R5-920
spellingShingle	brain tumor glioblastoma tumor targeting chitosan superparamagnetic iron oxide nanoparticles magnetic resonance imaging. Medicine (General) R5-920 Shevtsov M Nikolaev B Marchenko Y Yakovleva L Skvortsov N Mazur A Tolstoy P Ryzhov V Multhoff G Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
description	Maxim Shevtsov,1–4 Boris Nikolaev,5 Yaroslav Marchenko,5 Ludmila Yakovleva,5 Nikita Skvortsov,5 Anton Mazur,6 Peter Tolstoy,6 Vyacheslav Ryzhov,7 Gabriele Multhoff2 1Department of Cell Biotechnology, Institute of Cytology of the Russian Academy of Sciences, St Petersburg, Russia; 2Department of Radiation Immuno Oncology, Technische Universität München, Klinikum rechts der Isar, Munich, Germany; 3Department of Biotechnology, Pavlov First Saint Petersburg State Medical University, St Petersburg, Russia; 4Department of Pediatric Neurosurgery, Polenov Russian Scientific Research Institute of Neurosurgery, St Petersburg, Russia; 5Department of Nanomedicine, Research Institute of Highly Pure Biopreparations, St Petersburg, Russia; 6Department of NMR, Saint Petersburg State University, St Petersburg, Russia; 7Department of NMR, NRC “Kurchatov Institute”, Petersburg Nuclear Physics Institute, Gatchina, Russia Background: Glioblastoma is the most devastating primary brain tumor of the central nervous system in adults. Magnetic nanocarriers may help not only for a targeted delivery of chemotherapeutic agents into the tumor site but also provide contrast enhancing properties for diagnostics using magnetic resonance imaging (MRI).Methods: Synthesized hybrid chitosan-dextran superparamagnetic nanoparticles (CS-DX-SPIONs) were characterized using transmission electron microscopy (TEM) and relaxometry studies. Nonlinear magnetic response measurements were employed for confirming the superparamagnetic state of particles. Following in vitro analysis of nanoparticles cellular uptake tumor targeting was assessed in the model of the orthotopic glioma in rodents.Results: CS-DX-SPIONs nanoparticles showed a uniform diameter of 55 nm under TEM and superparamagentic characteristics as determined by T1 (spin-lattice relaxation time) and T2 (spin-spin relaxation time) proton relaxation times. Application of the chitosan increased the charge from +8.9 to +19.3 mV of the dextran-based SPIONs. The nonlinear magnetic response at second harmonic of CS-DX-SPIONs following the slow change of stationary magnetic fields with very low hysteresis evidenced superparamagnetic state of particles at ambient temperatures. Confocal microscopy and flow cytometry studies showed an enhanced internalization of the chitosan-based nanoparticles in U87, C6 glioma and HeLa cells as compared to dextran-coated particles. Cytotoxicity assay demonstrated acceptable toxicity profile of the synthesized nanoparticles up to a concentration of 10 µg/ml. Intravenously administered CS-DX-SPIONs in orthotopic C6 gliomas in rats accumulated in the tumor site as shown by high-resolution MRI (11.0 T). Retention of nanoparticles resulted in a significant contrast enhancement of the tumor image that was accompanied with a dramatic drop in T2 values (P<0.001). Subsequent histological studies proved the accumulation of the nanoparticles inside glioblastoma cells.Conclusion: Hybrid chitosan-dextran magnetic particles demonstrated high MR contrast enhancing properties for the delineation of the brain tumor. Due to a significant retention of the particles in the tumor an application of the CS-DX-SPIONs could not only improve the tumor imaging but also could allow a targeted delivery of chemotherapeutic agents. Keywords: brain tumor, glioblastoma, tumor targeting, chitosan, superparamagnetic iron oxide nanoparticles, magnetic resonance imaging
format	article
author	Shevtsov M Nikolaev B Marchenko Y Yakovleva L Skvortsov N Mazur A Tolstoy P Ryzhov V Multhoff G
author_facet	Shevtsov M Nikolaev B Marchenko Y Yakovleva L Skvortsov N Mazur A Tolstoy P Ryzhov V Multhoff G
author_sort	Shevtsov M
title	Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
title_short	Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
title_full	Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
title_fullStr	Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
title_full_unstemmed	Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
title_sort	targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (cs-dx-spions)
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/83ebd877e047494ab1723610e2cacd42
work_keys_str_mv	AT shevtsovm targetingexperimentalorthotopicglioblastomawithchitosanbasedsuperparamagneticironoxidenanoparticlescsdxspions AT nikolaevb targetingexperimentalorthotopicglioblastomawithchitosanbasedsuperparamagneticironoxidenanoparticlescsdxspions AT marchenkoy targetingexperimentalorthotopicglioblastomawithchitosanbasedsuperparamagneticironoxidenanoparticlescsdxspions AT yakovleval targetingexperimentalorthotopicglioblastomawithchitosanbasedsuperparamagneticironoxidenanoparticlescsdxspions AT skvortsovn targetingexperimentalorthotopicglioblastomawithchitosanbasedsuperparamagneticironoxidenanoparticlescsdxspions AT mazura targetingexperimentalorthotopicglioblastomawithchitosanbasedsuperparamagneticironoxidenanoparticlescsdxspions AT tolstoyp targetingexperimentalorthotopicglioblastomawithchitosanbasedsuperparamagneticironoxidenanoparticlescsdxspions AT ryzhovv targetingexperimentalorthotopicglioblastomawithchitosanbasedsuperparamagneticironoxidenanoparticlescsdxspions AT multhoffg targetingexperimentalorthotopicglioblastomawithchitosanbasedsuperparamagneticironoxidenanoparticlescsdxspions
_version_	1718402481778589696
spelling	oai:doaj.org-article:83ebd877e047494ab1723610e2cacd422021-12-02T02:26:26ZTargeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)1178-2013https://doaj.org/article/83ebd877e047494ab1723610e2cacd422018-03-01T00:00:00Zhttps://www.dovepress.com/targeting-experimental-orthotopic-glioblastoma-with-chitosan-based-sup-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Maxim Shevtsov,1–4 Boris Nikolaev,5 Yaroslav Marchenko,5 Ludmila Yakovleva,5 Nikita Skvortsov,5 Anton Mazur,6 Peter Tolstoy,6 Vyacheslav Ryzhov,7 Gabriele Multhoff2 1Department of Cell Biotechnology, Institute of Cytology of the Russian Academy of Sciences, St Petersburg, Russia; 2Department of Radiation Immuno Oncology, Technische Universität München, Klinikum rechts der Isar, Munich, Germany; 3Department of Biotechnology, Pavlov First Saint Petersburg State Medical University, St Petersburg, Russia; 4Department of Pediatric Neurosurgery, Polenov Russian Scientific Research Institute of Neurosurgery, St Petersburg, Russia; 5Department of Nanomedicine, Research Institute of Highly Pure Biopreparations, St Petersburg, Russia; 6Department of NMR, Saint Petersburg State University, St Petersburg, Russia; 7Department of NMR, NRC “Kurchatov Institute”, Petersburg Nuclear Physics Institute, Gatchina, Russia Background: Glioblastoma is the most devastating primary brain tumor of the central nervous system in adults. Magnetic nanocarriers may help not only for a targeted delivery of chemotherapeutic agents into the tumor site but also provide contrast enhancing properties for diagnostics using magnetic resonance imaging (MRI).Methods: Synthesized hybrid chitosan-dextran superparamagnetic nanoparticles (CS-DX-SPIONs) were characterized using transmission electron microscopy (TEM) and relaxometry studies. Nonlinear magnetic response measurements were employed for confirming the superparamagnetic state of particles. Following in vitro analysis of nanoparticles cellular uptake tumor targeting was assessed in the model of the orthotopic glioma in rodents.Results: CS-DX-SPIONs nanoparticles showed a uniform diameter of 55 nm under TEM and superparamagentic characteristics as determined by T1 (spin-lattice relaxation time) and T2 (spin-spin relaxation time) proton relaxation times. Application of the chitosan increased the charge from +8.9 to +19.3 mV of the dextran-based SPIONs. The nonlinear magnetic response at second harmonic of CS-DX-SPIONs following the slow change of stationary magnetic fields with very low hysteresis evidenced superparamagnetic state of particles at ambient temperatures. Confocal microscopy and flow cytometry studies showed an enhanced internalization of the chitosan-based nanoparticles in U87, C6 glioma and HeLa cells as compared to dextran-coated particles. Cytotoxicity assay demonstrated acceptable toxicity profile of the synthesized nanoparticles up to a concentration of 10 µg/ml. Intravenously administered CS-DX-SPIONs in orthotopic C6 gliomas in rats accumulated in the tumor site as shown by high-resolution MRI (11.0 T). Retention of nanoparticles resulted in a significant contrast enhancement of the tumor image that was accompanied with a dramatic drop in T2 values (P<0.001). Subsequent histological studies proved the accumulation of the nanoparticles inside glioblastoma cells.Conclusion: Hybrid chitosan-dextran magnetic particles demonstrated high MR contrast enhancing properties for the delineation of the brain tumor. Due to a significant retention of the particles in the tumor an application of the CS-DX-SPIONs could not only improve the tumor imaging but also could allow a targeted delivery of chemotherapeutic agents. Keywords: brain tumor, glioblastoma, tumor targeting, chitosan, superparamagnetic iron oxide nanoparticles, magnetic resonance imagingShevtsov MNikolaev BMarchenko YYakovleva LSkvortsov NMazur ATolstoy PRyzhov VMulthoff GDove Medical Pressarticlebrain tumorglioblastomatumor targetingchitosansuperparamagnetic iron oxide nanoparticlesmagnetic resonance imaging.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 1471-1482 (2018)

Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)

Ejemplares similares